Xiaoling Zhang

Nivolumab plus Ipilimumab in Advanced Melanoma

Jedd D. Wolchok, Harriet M. Kluger, Margaret K. Callahan et al. · New England Journal of Medicine · 2013 · 4.2K citations · Full text

Medicine, Oncology, Pharmacology +17

Late intellectual and academic outcomes following traumatic brain injury sustained during early childhood

Linda Ewing‐Cobbs, Mary R. Prasad, Larry A. Kramer et al. · Journal of Neurosurgery Pediatrics · 2006 · 243 citations · Full text

Education, Educational Assessment, Educational Measurement +16

Development of an Automated PD-L1 Immunohistochemistry (IHC) Assay for Non–Small Cell Lung Cancer

Thérèse Phillips, Pauline Simmons, H. David Inzunza et al. · Applied immunohistochemistry & molecular morphology · 2015 · 192 citations · Full text

Medicine, Immunology, Oncology +17

Association of tumor PD-L1 expression and immune biomarkers with clinical activity in patients (pts) with advanced solid tumors treated with nivolumab (anti-PD-1; BMS-936558; ONO-4538).

Joseph F. Grosso, Christine E. Horak, David Inzunza et al. · Journal of Clinical Oncology · 2013 · 159 citations

Life Sciences, Immunology, Oncology +17

FOXA1 overexpression suppresses interferon signaling and immune response in cancer

Yundong He, Liguo Wang, Ting Wei et al. · Journal of Clinical Investigation · 2021 · 89 citations · Full text

Medicine, Cancer Biology, Oncology +17